Westhive, providers of flexible office space, successfully closes its Series A financing round raising CHF 6.3 million. The round is co-led by the Fairway Family Office and Redstone powered MA Ventures, the corporate venture capital fund with Genossenschaft Migros Aare cooperative. The financing round is completed by other private and institutional investors. The new funds […]
Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch. Engimmune Therapeutics is a platform company using cutting-edge technologies
Inyova, a European impact investing platform, managed approximately CHF 173 million in assets as of the end of February 2022. The capital raised through the crowdinvesting is expected to enable the development of new features such as
Fu-Gen, an independent power producer and investor in renewable energy, has secured a strategic investment of more than EUR 320 million that will enable the company to advance renewable energy development. The funding received will be
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
The engineering intelligence company Neural Concept raises a CHF 9,1 Mio Serie A investment to scale Engineering Intelligence within industrial organizations. With the financing round the company will fuel further growth as the recruiting of more
SonarSource, a platform for clean code, has completed a growth equity financing by General Catalyst, Advent International, Insight Partners, and Permira’s Growth Opportunities Fund. The financing raised USD 412 million in new investment
beqom, a company sponsored inter alia by Goldman Sachs and Eurazeo, receives a USD300 million investment by Sumeru Equity Partners and co-investors. Majority of the investment will fuel additional growth in product innovation to better
Versant Ventures debut Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies. Versant has made a USD 50m Series A commitment to Cimeio, which is the most recent start-up to emerge from
Alpian, a company incubated by REYL Intesa Sanpaolo, applied for a full banking licence from the SwissFinancial Market Supervisory Authority (FINMA). After a rigorous process, Alpian has become the first licensed digital private bank in
